Turn Therapeutics Inc. Common Stock TTRX Balance Sheet Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| $5.08M+482% | $872.6K-26.1% | ||
| $5.2M+373% | $1.1M— | ||
| $922.17K+12.2% | $821.93K— | ||
| $12.16M+494% | $2.05M— | ||
| $6M+748% | $707.93K— | ||
| —— | —— | ||
| $7.48M+236% | $2.23M— | ||
| $500M+18,628,812% | $2.68K— | ||
| -$22.39M-16.6% | -$19.2M— | ||
| $4.69M+2,741% | -$177.43K-307% | ||
| $12.16M+494% | $2.05M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Turn Therapeutics Inc. Common Stock's total assets?
- Turn Therapeutics Inc. Common Stock (TTRX) holds $18.6M in total assets.
- How much debt does Turn Therapeutics Inc. Common Stock have?
- Turn Therapeutics Inc. Common Stock carries $6.0M in total debt against $6.1M of shareholders' equity, a debt-to-equity ratio of 0.98.
- How much cash does Turn Therapeutics Inc. Common Stock have?
- Turn Therapeutics Inc. Common Stock holds $11.2M in cash and equivalents.
- Can Turn Therapeutics Inc. Common Stock cover its short-term obligations?
- Its current ratio is 2.23 — current assets exceed current liabilities.
- Where does Turn Therapeutics Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Turn Therapeutics Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.